| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/01/2004 | EP1451166A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 08/26/2004 | US20040167031 Arylphenyl-substituted cyclic ketoenols |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP0755458B1 Electrogenerated chemiluminescence labels for analysis and/or referencing |
| 08/25/2004 | CN1163490C Method for preparing cyclic thioamide compound |
| 08/24/2004 | CA2308281C 3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4[10h]-one derivatives |
| 08/19/2004 | US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/17/2004 | US6777446 Farnesoid x receptor; treating diseases associated with abnormally high or low cholesterol levels. |
| 08/12/2004 | US20040158061 Reaction of (di)amines in the presence of a lysine oxidase and of a reducing agent |
| 08/11/2004 | CN1519230A Process of preparing cyclic thioacid amide compound |
| 08/11/2004 | CN1161331C Hydrazine derivatives |
| 08/05/2004 | WO2004065366A1 2.4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 08/05/2004 | US20040152745 Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors |
| 08/05/2004 | US20040152696 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
| 08/05/2004 | CA2513501A1 2.4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/03/2004 | US6770668 Pharmaceutically active compounds and methods of use |
| 07/29/2004 | WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | WO2003105811A3 Controlled release compositions and methods for using same |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040146746 Diphenyl anthracene derivatives and organic electroluminescent device employing the same |
| 07/29/2004 | DE10301804A1 New 6-alkyl-2,4-dihalophenyl-substituted tetramic acid derivatives, useful as herbicides and pesticides, especially insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/28/2004 | EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/28/2004 | EP0823897B1 Nicotinic acid esters and pharmaceutical compositions containing them |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/27/2004 | CA2177753C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof |
| 07/27/2004 | CA2124136C Method for producing benzylidene derivatives |
| 07/27/2004 | CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | US20040142928 particularly against herpes viruses |
| 07/21/2004 | CN1514831A Medicinal composition containing 1,3-thiazine derivative |
| 07/21/2004 | CN1514829A Novel herbicides |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/15/2004 | US20040137273 Red color emitting compounds for organic electroluminescent device and an organic electroluminescent device using them |
| 07/14/2004 | EP1436270A1 Novel benzothiazine derivatives, their preparation and use |
| 07/14/2004 | EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 07/14/2004 | EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | CN1157365C Monoamine reuptake inhibitors for treatment of CNS disorders |
| 07/08/2004 | US20040132719 Phenothiazine kinesin inhibitors |
| 07/07/2004 | EP1435384A2 Red light emitting compounds for organic electroluminescent devices and organic electroluminescent devices using them |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | CN1156460C Preparation method of mixture of phenthiazine alkylate and diphenylamine |
| 07/06/2004 | US6759548 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/06/2004 | US6759406 Quaternary ammonium compounds |
| 06/30/2004 | EP1009743B1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 06/30/2004 | EP0971908B1 Il-8 receptor antagonists |
| 06/24/2004 | US20040122003 Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions |
| 06/24/2004 | US20040121490 Metal chelate containing compositions for use in chemiluminescent assays |
| 06/24/2004 | US20040121262 Transient optical state change materials useful in copy-protected compact discs |
| 06/23/2004 | EP1429844A2 Conjugated anti-psychotic drugs and uses thereof |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/17/2004 | WO2004050623A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | WO2004050619A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | WO2004018414A3 Antibacterial agents |
| 06/17/2004 | US20040116456 Remedies for psychoneurosis |
| 06/17/2004 | US20040116412 Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions |
| 06/17/2004 | US20040116326 Medicinal composition containing 1,3-thiazine derivative |
| 06/17/2004 | CA2508325A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | CA2507875A1 Methods for preparing phenylalkyne derivatives |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/10/2004 | WO2003059265A3 Compositions and methods for treating heart failure |
| 06/10/2004 | US20040110802 Antibacterial benzoic acid derivatives |
| 06/09/2004 | CN1152860C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/02/2004 | EP1423151A1 Light-stabilized $i(in vivo) stain composition and method of manufacture |
| 06/02/2004 | CN1152020C Benzimidazolrone and analogues, and uses as progesterone ligand thereof |
| 06/01/2004 | US6743373 Reagent based on enantiopure amino acid in which amino group carries activating group to form active precursor of isocyanate group and carboxyl group is substituted; separation of enantiomers having free functional group |
| 05/27/2004 | WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/27/2004 | WO2003062388A9 Inhibition of rna function |
| 05/26/2004 | EP1421389A2 Neurofibrillary labels |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/21/2004 | WO2003103569A3 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 05/20/2004 | US20040094749 Having improved solubility and handling properties |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | CN1150404C Inhibition of Tau-Tau association |
| 05/12/2004 | EP1418430A2 A homogeneous assay for determining analyte |
| 05/12/2004 | EP1417187A1 Aryl substituted thiazolidinones and the use thereof |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | EP1414806A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 04/29/2004 | WO2004014388A8 6,6-fused heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 04/28/2004 | CN1147482C Substittued (dihydro) benzoxazole and (dihydro)benzoxazine compound and its preparation and medicine composite |
| 04/22/2004 | WO2003026563A9 Conjugated anti-psychotic drugs and uses thereof |
| 04/21/2004 | EP1409691A2 Stereoselective preparation of cyclic l-amino acids |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/15/2004 | WO2004031134A1 Process for making substituted aryl sulfonamides using an indium based catalyst system |
| 04/15/2004 | US20040072825 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy) ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof |